8E2-31216-09218
4 vaccinations
5 coded responses
27 check-ins
5 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 56-60
- ZIP prefix
- 922 / CA
- Registered
- 2021-01-12
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-12
Registered in v-safe
-
2021-01-12
Dose 1 — Pfizer-BioNTech
- 2021-01-12
-
2021-01-13
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-13
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
- 2021-01-14
- 2021-01-16
- 2021-01-17
- 2021-01-18
- 2021-01-19
- 2021-01-26
-
2021-02-02
Dose 2 — Pfizer-BioNTech
- 2021-02-02
-
2021-02-03
Health check-in — days 1–6 daily, dose 2Feeling: Good · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-02-04
Survey response — days 1–6 daily, dose 2MedDRA: Dizziness, Mental fatigue — Feeling: Fair · Headache, Fatigue or tirednessFree text: Dizzy, mental fatigueMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-05
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
- 2021-02-06
- 2021-02-07
- 2021-02-08
-
2021-02-09
Survey response — day 7, dose 2MedDRA: Heart rate increased — Feeling: GoodFree text: My heart rate has been elevated over the last week.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-18
Survey response — day 14, dose 2MedDRA: Asthenia — Feeling: GoodFree text: My physical energy drains more quickly than it did pre-vaccine.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-23
- 2021-03-02
- 2021-03-09
- 2021-03-16
-
2021-05-04
Survey response — 3 months, dose 2MedDRA: Chills, Diarrhoea, Fatigue, Headache, Nausea, Pain, Pyrexia — Feeling: Fair · Be unable to do your normal daily activitiesFree text: 2 days of diarrhea, fever, aches, chills, headache followed by 5 days of nausea and fatigue (currently at day 7, nausea is diminishing).MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-08-03
-
2021-11-23
Dose 3 — Pfizer-BioNTech
- 2022-02-02
-
2022-05-15
Dose 4 — Pfizer-BioNTech
-
2022-08-16
Survey response — 3 months, dose 4MedDRA: Condition aggravated, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Fibromyalgia flared up three weeks after 2nd booster and has continued for 9 weeks (so far). Fibro had been well controlled for 2 years.MedDRA releases: 2024-11 · check-in free text available
-
2022-08-16
Report sent to call center — 3 months, dose 4Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-08-17
Call successfulParticipant prefers to complete VAERS report online
- 2022-11-13
- 2023-05-15
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-12 | Pfizer-BioNTech | |
| 2 | 2021-02-02 | Pfizer-BioNTech | |
| 3 | 2021-11-23 | Pfizer-BioNTech | No |
| 4 | 2022-05-15 | Pfizer-BioNTech | No |
Call center
2 call center cases
1 successful · 1 priority 2/3 (triaged and no follow up)
Free text
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): Dizzy, mental fatigue
Release 3 — day 7, dose 2
Systemic reaction (other): My heart rate has been elevated over the last week.
Release 4 — day 14, dose 2
Symptoms: My physical energy drains more quickly than it did pre-vaccine.
Release 8 — 3 months, dose 2
Symptoms: 2 days of diarrhea, fever, aches, chills, headache followed by 5 days of nausea and fatigue (currently at day 7, nausea is diminishing).
Release 12 — 3 months, dose 4
Symptoms: Fibromyalgia flared up three weeks after 2nd booster and has continued for 9 weeks (so far). Fibro had been well controlled for 2 years.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Asthenia | ✓ | ✓ | ✓ |
| SD | Chills | ✓ | ✓ | ✓ |
| SD | Condition aggravated | · | · | ✓ |
| SD | Diarrhoea | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Nausea | ✓ | ✓ | ✓ |
| SD | Pain | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Pyrexia | ✓ | ✓ | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Heart rate increased | ✓ | ✓ | ✓ |
| SRO | Mental fatigue | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release